American Century Companies Inc Adaptive Biotechnologies Corp Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, American Century Companies Inc holds 71,165 shares of ADPT stock, worth $333,763. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,165

Previous 45,562 56.19%

Holding current value

$333,763

Previous $164,000 121.95%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.37 - $5.12 $86,282 - $131,087	25,603 Added 56.19%	71,165 $364,000
Q2 2024 Aug 07, 2024	BUY	$2.34 - $3.96 $16,471 - $27,874	7,039 Added 18.27%	45,562 $164,000
Q1 2024 May 14, 2024	SELL	$2.88 - $4.8 $2.25 Million - $3.76 Million	-782,914 Reduced 95.31%	38,523 $123,000
Q4 2023 Feb 13, 2024	BUY	$3.46 - $5.33 $2.84 Million - $4.38 Million	821,437 New	821,437 $4.03 Million
Q3 2023 Nov 13, 2023	BUY	$5.07 - $8.44 $438,443 - $729,874	86,478 Added 11.72%	824,318 $4.49 Million
Q2 2023 Aug 14, 2023	BUY	$6.19 - $8.78 $433 - $614	70 Added 0.01%	737,840 $4.95 Million
Q1 2023 May 11, 2023	BUY	$7.8 - $10.11 $1.24 Million - $1.61 Million	159,372 Added 27.55%	737,770 $6.51 Million
Q4 2022 Feb 13, 2023	BUY	$6.26 - $9.34 $1.1 Million - $1.65 Million	176,441 Added 43.9%	578,398 $4.42 Million
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $1.43 Million - $2.79 Million	220,266 Added 121.23%	401,957 $2.86 Million
Q2 2022 Aug 12, 2022	BUY	$6.4 - $14.73 $13,216 - $30,417	2,065 Added 1.15%	181,691 $1.47 Million
Q1 2022 May 11, 2022	SELL	$10.12 - $28.9 $19,005 - $54,274	-1,878 Reduced 1.03%	179,626 $2.49 Million
Q4 2021 Feb 07, 2022	BUY	$25.17 - $36.85 $1.45 Million - $2.12 Million	57,642 Added 46.54%	181,504 $5.09 Million
Q3 2021 Nov 10, 2021	BUY	$30.02 - $39.87 $4,262 - $5,661	142 Added 0.11%	123,862 $4.21 Million
Q2 2021 Aug 05, 2021	BUY	$32.22 - $44.59 $3.99 Million - $5.52 Million	123,720 New	123,720 $5.06 Million
Q1 2021 May 14, 2021	SELL	$37.26 - $67.74 $35.4 Million - $64.3 Million	-948,837 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$45.01 - $65.47 $2,160 - $3,142	-48 Reduced 0.01%	948,837 $56.1 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $5.29 Million - $7.21 Million	147,714 Added 18.44%	948,885 $46.1 Million
Q2 2020 Aug 13, 2020	BUY	$24.95 - $48.38 $20 Million - $38.8 Million	801,171 New	801,171 $38.8 Million
Q3 2019 Nov 13, 2019	SELL	$30.31 - $53.51 $5.37 Million - $9.48 Million	-177,091 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $7.14 Million - $8.55 Million	177,091 New	177,091 $8.55 Million

Others Institutions Holding ADPT

# of Institutions

201

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $670M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Adaptive Biotechnologies Corp Transaction History